课题基金 / 基金详情

Targeted Cancer Chemotherapy by Nanoparticle-based Drug Delivery

Targeted Cancer Chemotherapy by Nanoparticle-based Drug Delivery
基于纳米颗粒的药物输送的靶向癌症化疗
批准号：
268671
负责人：
Li Shyh-Dar
金额：
$21.86万
依托单位：
Ontario Institute for Cancer Research (Toronto, Ontario)
依托单位国家：
加拿大
项目类别：
Salary Programs
财政年份：
2012
资助国家：
加拿大
项目状态：
已结题
起止时间：
2012-09-01 至 2017-09-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=268671&lang=en
关键词：
Cancer Chemotherapy Drug Delivery Nanoparticle

项目摘要

项目成果

Li Shyh-Dar的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Chemotherapy is often the standard of care for advanced cancer. However, non-specific delivery of the chemotherapeutics results in significant side effects, reducing the therapeutic outcome and patients' quality of life. Dr. Li's research is focused on de
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Validation and commercialization of an innovative analgesic for chronic pain
  • 批准号：
    408033
  • 项目类别：
    Operating Grants
  • 资助金额：
    $38.18万
  • 财政年份：
    2019
  • 负责人：
    Li Shyh-Dar
  • 依托单位：
    University of British Columbia
Development of child-friendly oral formulations for drugs used in the maintenance therapy of childhood acute lymphoblastic leukemia
  • 批准号：
    343659
  • 项目类别：
    Operating Grants
  • 资助金额：
    $25.06万
  • 财政年份：
    2016
  • 负责人：
    Li Shyh-Dar
  • 依托单位：
    University of British Columbia
Heat-triggered Chemotherapy to Treat Refractory Breast Cancer at the Chest Wall
Benchmark Cellax, a proprietary nanoparticle formulation for docetaxel, against Taxotere to treat metastatic castration resistant prostate cancer
海外基金